Evotec SE (EVO) Gross Profit Growth (3y) (2022 - 2025)
Evotec SE (EVO) Gross Profit Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.02 Bn | 32.28 Bn | 1.97 Bn | 7.62% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | 4.71% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -7.64% |
| 5 | United Therapeutics | 23.09 Bn | 20.94 Bn | 648.10 Mn | 12.55% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.54 Bn | 1.16 Bn | -9.13% |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 24.80% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 0.95% |
| 10 | Evotec SE | 345.39 Mn | 344.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.75% |
| Sep 30, 2025 | -1,262.87% |
| Dec 31, 2024 | -24.35% |
| Sep 30, 2024 | -26.66% |
| Dec 31, 2023 | 11.60% |
| Sep 30, 2023 | -0.81% |
| Dec 31, 2022 | -91.40% |